Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2004 Oct;80(948):588–601. doi: 10.1136/pgmj.2004.019638

Dengue viral infections

G Malavige 1, S Fernando 1, D Fernando 1, S Seneviratne 1
PMCID: PMC1743110  PMID: 15466994

Abstract

Dengue viral infections are one of the most important mosquito borne diseases in the world. They may be asymptomatic or may give rise to undifferentiated fever, dengue fever, dengue haemorrhagic fever (DHF), or dengue shock syndrome. Annually, 100 million cases of dengue fever and half a million cases of DHF occur worldwide. Ninety percent of DHF subjects are children less than 15 years of age. At present, dengue is endemic in 112 countries in the world. No vaccine is available for preventing this disease. Early recognition and prompt initiation of appropriate treatment are vital if disease related morbidity and mortality are to be limited. This review outlines aspects of the epidemiology of dengue infections, the dengue virus and its mosquito vector, clinical features and pathogenesis of dengue infections, and the management and control of these infections.

Full Text

The Full Text of this article is available as a PDF (259.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agarwal R., Kapoor S., Nagar R., Misra A., Tandon R., Mathur A., Misra A. K., Srivastava K. L., Chaturvedi U. C. A clinical study of the patients with dengue hemorrhagic fever during the epidemic of 1996 at Lucknow, India. Southeast Asian J Trop Med Public Health. 1999 Dec;30(4):735–740. [PubMed] [Google Scholar]
  2. Aggarwal A., Chandra J., Aneja S., Patwari A. K., Dutta A. K. An epidemic of dengue hemorrhagic fever and dengue shock syndrome in children in Delhi. Indian Pediatr. 1998 Aug;35(8):727–732. [PubMed] [Google Scholar]
  3. Anuradha S., Singh N. P., Rizvi S. N., Agarwal S. K., Gur R., Mathur M. D. The 1996 outbreak of dengue hemorrhagic fever in Delhi, India. Southeast Asian J Trop Med Public Health. 1998 Sep;29(3):503–506. [PubMed] [Google Scholar]
  4. Azeredo E. L., Zagne S. M., Santiago M. A., Gouvea A. S., Santana A. A., Neves-Souza P. C., Nogueira R. M., Miagostovich M. P., Kubelka C. F. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology. 2001 Dec;204(4):494–507. doi: 10.1078/0171-2985-00058. [DOI] [PubMed] [Google Scholar]
  5. Boonpucknavig S., Vuttiviroj O., Bunnag C., Bhamarapravati N., Nimmanitya S. Demonstration of dengue antibody complexes on the surface of platelets from patients with dengue hemorrhagic fever. Am J Trop Med Hyg. 1979 Sep;28(5):881–884. [PubMed] [Google Scholar]
  6. Branch S. L., Levett P. N. Evaluation of four methods for detection of immunoglobulin M antibodies to dengue virus. Clin Diagn Lab Immunol. 1999 Jul;6(4):555–557. doi: 10.1128/cdli.6.4.555-557.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bravo J. R., Guzmán M. G., Kouri G. P. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hyg. 1987;81(5):816–820. doi: 10.1016/0035-9203(87)90041-1. [DOI] [PubMed] [Google Scholar]
  8. Cam B. V., Fonsmark L., Hue N. B., Phuong N. T., Poulsen A., Heegaard E. D. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg. 2001 Dec;65(6):848–851. doi: 10.4269/ajtmh.2001.65.848. [DOI] [PubMed] [Google Scholar]
  9. Cardosa Mary Jane, Wang Seok Mui, Sum Magdline Sia H., Tio Phaik Hooi. Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses. BMC Microbiol. 2002 May 5;2:9–9. doi: 10.1186/1471-2180-2-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Castle T., Amador M., Rawlins S., Figueroa J. P., Reiter P. Absence of impact of aerial malathion treatment on Aedes aegypti during a dengue outbreak in Kingston, Jamaica. Rev Panam Salud Publica. 1999 Feb;5(2):100–105. doi: 10.1590/s1020-49891999000200005. [DOI] [PubMed] [Google Scholar]
  11. Chareonsook O., Foy H. M., Teeraratkul A., Silarug N. Changing epidemiology of dengue hemorrhagic fever in Thailand. Epidemiol Infect. 1999 Feb;122(1):161–166. doi: 10.1017/s0950268898001617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chaturvedi U. C., Dhawan R., Khanna M., Mathur A. Breakdown of the blood-brain barrier during dengue virus infection of mice. J Gen Virol. 1991 Apr;72(Pt 4):859–866. doi: 10.1099/0022-1317-72-4-859. [DOI] [PubMed] [Google Scholar]
  13. Chaturvedi U. C., Elbishbishi E. A., Agarwal R., Mustafa A. S. Cytotoxic factor-autoantibodies: possible role in the pathogenesis of dengue haemorrhagic fever. FEMS Immunol Med Microbiol. 2001 Apr;30(3):181–186. doi: 10.1111/j.1574-695X.2001.tb01568.x. [DOI] [PubMed] [Google Scholar]
  14. Chaturvedi U. C., Elbishbishi E. A., Agarwal R., Raghupathy R., Nagar R., Tandon R., Pacsa A. S., Younis O. I., Azizieh F. Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. J Med Virol. 1999 Nov;59(3):335–340. doi: 10.1002/(sici)1096-9071(199911)59:3<335::aid-jmv13>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  15. Chuansumrit A., Phimolthares V., Tardtong P., Tapaneya-Olarn C., Tapaneya-Olarn W., Kowsathit P., Chantarojsiri T. Transfusion requirements in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health. 2000 Mar;31(1):10–14. [PubMed] [Google Scholar]
  16. Cunha R. V., Schatzmayr H. G., Miagostovich M. P., Barbosa A. M., Paiva F. G., Miranda R. M., Ramos C. C., Coelho J. C., dos Santos F. B., Nogueira R. M. Dengue epidemic in the State of Rio Grande do Norte, Brazil, in 1997. Trans R Soc Trop Med Hyg. 1999 May-Jun;93(3):247–249. doi: 10.1016/s0035-9203(99)90008-1. [DOI] [PubMed] [Google Scholar]
  17. Dar L., Broor S., Sengupta S., Xess I., Seth P. The first major outbreak of dengue hemorrhagic fever in Delhi, India. Emerg Infect Dis. 1999 Jul-Aug;5(4):589–590. doi: 10.3201/eid0504.990427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. De Paula Sérgio Oliveira, Pires Neto Roberto J., Corrêa Joseane A. C. Tocantins, Assumpço Silvia R., Costa Márcia L. S., Lima Danielle Malta, Fonseca Benedito Antônio Lopes. The use of reverse transcription-polymerase chain reaction (RT-PCR) for the rapid detection and identification of dengue virus in an endemic region: a validation study. Trans R Soc Trop Med Hyg. 2002 May-Jun;96(3):266–269. doi: 10.1016/s0035-9203(02)90094-5. [DOI] [PubMed] [Google Scholar]
  19. Dung N. M., Day N. P., Tam D. T., Loan H. T., Chau H. T., Minh L. N., Diet T. V., Bethell D. B., Kneen R., Hien T. T. Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis. 1999 Oct;29(4):787–794. doi: 10.1086/520435. [DOI] [PubMed] [Google Scholar]
  20. Endy Timothy P., Nisalak Ananda, Chunsuttiwat Supamit, Libraty Daniel H., Green Sharone, Rothman Alan L., Vaughn David W., Ennis Francis A. Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol. 2002 Jul 1;156(1):52–59. doi: 10.1093/aje/kwf006. [DOI] [PubMed] [Google Scholar]
  21. Fan W. F., Yu S. R., Cosgriff T. M. The reemergence of dengue in China. Rev Infect Dis. 1989 May-Jun;11 (Suppl 4):S847–S853. doi: 10.1093/clinids/11.supplement_4.s847. [DOI] [PubMed] [Google Scholar]
  22. Gagnon S. J., Ennis F. A., Rothman A. L. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J Virol. 1999 May;73(5):3623–3629. doi: 10.1128/jvi.73.5.3623-3629.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gilbreath M. J., Pavanand K., MacDermott R. P., Ussery M., Burke D. S., Nimmannitya S., Tulyayon S. Cold-reactive immunoglobulin M antilymphocyte antibodies directed against B cells in Thai children with dengue hemorrhagic fever. J Clin Microbiol. 1983 Apr;17(4):672–676. doi: 10.1128/jcm.17.4.672-676.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Green S., Vaughn D. W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., Lew R., Innis B. L., Kurane I., Rothman A. L. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis. 1999 Apr;179(4):755–762. doi: 10.1086/314680. [DOI] [PubMed] [Google Scholar]
  25. Guzman M. G., Kouri G. P., Bravo J., Soler M., Vazquez S., Santos M., Villaescusa R., Basanta P., Indan G., Ballester J. M. Dengue haemorrhagic fever in Cuba. II. Clinical investigations. Trans R Soc Trop Med Hyg. 1984;78(2):239–241. doi: 10.1016/0035-9203(84)90286-4. [DOI] [PubMed] [Google Scholar]
  26. Guzman M. G., Kouri G., Soler M., Bravo J., Rodríguez de La Vega A., Vazquez S., Mune M. Dengue 2 virus enhancement in asthmatic and non asthmatic individual. Mem Inst Oswaldo Cruz. 1992 Oct-Dec;87(4):559–564. doi: 10.1590/s0074-02761992000400016. [DOI] [PubMed] [Google Scholar]
  27. Guzman María G., Kouri Gustavo. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol. 2003 May;27(1):1–13. doi: 10.1016/s1386-6532(03)00010-6. [DOI] [PubMed] [Google Scholar]
  28. Guzmán Tirado M. G., Kourí Flores G., Bravo González J. R. La emergencia de la fiebre hemorrágica del dengue en las Américas. Reemergencia del dengue. Rev Cubana Med Trop. 1999 Jan-Apr;51(1):5–13. [PubMed] [Google Scholar]
  29. Guzmán M. G., Alvarez M., Rodríguez R., Rosario D., Vázquez S., Vald s L., Cabrera M. V., Kourí G. Fatal dengue hemorrhagic fever in Cuba, 1997. Int J Infect Dis. 1999 Spring;3(3):130–135. doi: 10.1016/s1201-9712(99)90033-4. [DOI] [PubMed] [Google Scholar]
  30. Guzmán M. G., Kouri G. P., Bravo J., Soler M., Vazquez S., Morier L. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg. 1990 Feb;42(2):179–184. doi: 10.4269/ajtmh.1990.42.179. [DOI] [PubMed] [Google Scholar]
  31. Guzmán M. G., Kourí G. Advances in dengue diagnosis. Clin Diagn Lab Immunol. 1996 Nov;3(6):621–627. doi: 10.1128/cdli.3.6.621-627.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Guzmán María G., Kouri Gustavo, Bravo Jose, Valdes Luis, Vazquez Susana, Halstead Scott B. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis. 2002 Jun;6(2):118–124. doi: 10.1016/s1201-9712(02)90072-x. [DOI] [PubMed] [Google Scholar]
  33. Guzmán María G., Kourí Gustavo. Dengue: an update. Lancet Infect Dis. 2002 Jan;2(1):33–42. doi: 10.1016/s1473-3099(01)00171-2. [DOI] [PubMed] [Google Scholar]
  34. HOLLIDAY M. A., SEGAR W. E. The maintenance need for water in parenteral fluid therapy. Pediatrics. 1957 May;19(5):823–832. [PubMed] [Google Scholar]
  35. Ha D. Q., Tien N. T., Huong V. T., Loan H. T., Thang C. M. Dengue epidemic in southern Vietnam, 1998. Emerg Infect Dis. 2000 Jul-Aug;6(4):422–425. doi: 10.3201/eid0604.000421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Halstead S. B. Is there an inapparent dengue explosion? Lancet. 1999 Mar 27;353(9158):1100–1101. doi: 10.1016/S0140-6736(05)76460-6. [DOI] [PubMed] [Google Scholar]
  37. Halstead S. B. Pathogenesis of dengue: challenges to molecular biology. Science. 1988 Jan 29;239(4839):476–481. doi: 10.1126/science.3277268. [DOI] [PubMed] [Google Scholar]
  38. Halstead S. B., Streit T. G., Lafontant J. G., Putvatana R., Russell K., Sun W., Kanesa-Thasan N., Hayes C. G., Watts D. M. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg. 2001 Sep;65(3):180–183. doi: 10.4269/ajtmh.2001.65.180. [DOI] [PubMed] [Google Scholar]
  39. Halstead S. B., Streit T. G., Lafontant J. G., Putvatana R., Russell K., Sun W., Kanesa-Thasan N., Hayes C. G., Watts D. M. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg. 2001 Sep;65(3):180–183. doi: 10.4269/ajtmh.2001.65.180. [DOI] [PubMed] [Google Scholar]
  40. Halstead Scott B., Lan Nguyen Trong, Myint Thein Thein, Shwe Than Nu, Nisalak Ananda, Kalyanarooj Siripen, Nimmannitya Suchitra, Soegijanto Soegeng, Vaughn David W., Endy Timothy P. Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg Infect Dis. 2002 Dec;8(12):1474–1479. doi: 10.3201/eid0812.020170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Hathirat P., Isarangkura P., Srichaikul T., Suvatte V., Mitrakul C. Abnormal hemostasis in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health. 1993;24 (Suppl 1):80–85. [PubMed] [Google Scholar]
  42. Henchal E. A., McCown J. M., Seguin M. C., Gentry M. K., Brandt W. E. Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay. Am J Trop Med Hyg. 1983 Jan;32(1):164–169. doi: 10.4269/ajtmh.1983.32.164. [DOI] [PubMed] [Google Scholar]
  43. Ho L. J., Wang J. J., Shaio M. F., Kao C. L., Chang D. M., Han S. W., Lai J. H. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol. 2001 Feb 1;166(3):1499–1506. doi: 10.4049/jimmunol.166.3.1499. [DOI] [PubMed] [Google Scholar]
  44. Ho L. J., Wang J. J., Shaio M. F., Kao C. L., Chang D. M., Han S. W., Lai J. H. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol. 2001 Feb 1;166(3):1499–1506. doi: 10.4049/jimmunol.166.3.1499. [DOI] [PubMed] [Google Scholar]
  45. Hongsiriwon Suchat. Dengue hemorrhagic fever in infants. Southeast Asian J Trop Med Public Health. 2002 Mar;33(1):49–55. [PubMed] [Google Scholar]
  46. Huang Y. H., Lei H. Y., Liu H. S., Lin Y. S., Liu C. C., Yeh T. M. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg. 2000 Jul-Aug;63(1-2):71–75. doi: 10.4269/ajtmh.2000.63.71. [DOI] [PubMed] [Google Scholar]
  47. Huang Y. H., Liu C. C., Wang S. T., Lei H. Y., Liu H. L., Lin Y. S., Wu H. L., Yeh T. M. Activation of coagulation and fibrinolysis during dengue virus infection. J Med Virol. 2001 Mar;63(3):247–251. doi: 10.1002/1096-9071(200103)63:3<247::aid-jmv1008>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  48. Huerre M. R., Lan N. T., Marianneau P., Hue N. B., Khun H., Hung N. T., Khen N. T., Drouet M. T., Huong V. T., Ha D. Q. Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children. Virchows Arch. 2001 Feb;438(2):107–115. doi: 10.1007/s004280000329. [DOI] [PubMed] [Google Scholar]
  49. Isarangkura P., Tuchinda S. The behavior of transfused platelets in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health. 1993;24 (Suppl 1):222–224. [PubMed] [Google Scholar]
  50. Joshi Vinod, Mourya D. T., Sharma R. C. Persistence of dengue-3 virus through transovarial transmission passage in successive generations of Aedes aegypti mosquitoes. Am J Trop Med Hyg. 2002 Aug;67(2):158–161. doi: 10.4269/ajtmh.2002.67.158. [DOI] [PubMed] [Google Scholar]
  51. Juffrie M., Meer G. M., Hack C. E., Haasnoot K., Sutaryo, Veerman A. J., Thijs L. G. Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am J Trop Med Hyg. 2001 Jul;65(1):70–75. doi: 10.4269/ajtmh.2001.65.70. [DOI] [PubMed] [Google Scholar]
  52. Juffrie M., van Der Meer G. M., Hack C. E., Haasnoot K., Sutaryo, Veerman A. J., Thijs L. G. Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation. Infect Immun. 2000 Feb;68(2):702–707. doi: 10.1128/iai.68.2.702-707.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Kabra S. K., Jain Y., Pandey R. M., Madhulika, Singhal T., Tripathi P., Broor S., Seth P., Seth V. Dengue haemorrhagic fever in children in the 1996 Delhi epidemic. Trans R Soc Trop Med Hyg. 1999 May-Jun;93(3):294–298. doi: 10.1016/s0035-9203(99)90027-5. [DOI] [PubMed] [Google Scholar]
  54. Kabra S. K., Jain Y., Pandey R. M., Madhulika, Singhal T., Tripathi P., Broor S., Seth P., Seth V. Dengue haemorrhagic fever in children in the 1996 Delhi epidemic. Trans R Soc Trop Med Hyg. 1999 May-Jun;93(3):294–298. doi: 10.1016/s0035-9203(99)90027-5. [DOI] [PubMed] [Google Scholar]
  55. Kabra S. K., Jain Y., Pandey R. M., Madhulika, Singhal T., Tripathi P., Broor S., Seth P., Seth V. Dengue haemorrhagic fever in children in the 1996 Delhi epidemic. Trans R Soc Trop Med Hyg. 1999 May-Jun;93(3):294–298. doi: 10.1016/s0035-9203(99)90027-5. [DOI] [PubMed] [Google Scholar]
  56. Kabra S. K., Jain Y., Singhal T., Ratageri V. H. Dengue hemorrhagic fever: clinical manifestations and management. Indian J Pediatr. 1999 Jan-Feb;66(1):93–101. doi: 10.1007/BF02752362. [DOI] [PubMed] [Google Scholar]
  57. Kabra S. K., Juneja R., Madhulika, Jain Y., Singhal T., Dar L., Kothari S. S., Broor S. Myocardial dysfunction in children with dengue haemorrhagic fever. Natl Med J India. 1998 Mar-Apr;11(2):59–61. [PubMed] [Google Scholar]
  58. Kalayanarooj S., Vaughn D. W., Nimmannitya S., Green S., Suntayakorn S., Kunentrasai N., Viramitrachai W., Ratanachu-eke S., Kiatpolpoj S., Innis B. L. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis. 1997 Aug;176(2):313–321. doi: 10.1086/514047. [DOI] [PubMed] [Google Scholar]
  59. Kanesa-thasan N., Sun W., Kim-Ahn G., Van Albert S., Putnak J. R., King A., Raengsakulsrach B., Christ-Schmidt H., Gilson K., Zahradnik J. M. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine. 2001 Apr 30;19(23-24):3179–3188. doi: 10.1016/s0264-410x(01)00020-2. [DOI] [PubMed] [Google Scholar]
  60. Kay Brian H., Nam Vu Sinh, Tien Tran Van, Yen Nguyen Thi, Phong Tran Vu, Diep Vu Thi Bich, Ninh Truong Uyen, Bektas Ahmet, Aaskov John G. Control of aedes vectors of dengue in three provinces of Vietnam by use of Mesocyclops (Copepoda) and community-based methods validated by entomologic, clinical, and serological surveillance. Am J Trop Med Hyg. 2002 Jan;66(1):40–48. doi: 10.4269/ajtmh.2002.66.40. [DOI] [PubMed] [Google Scholar]
  61. King C. A., Marshall J. S., Alshurafa H., Anderson R. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol. 2000 Aug;74(15):7146–7150. doi: 10.1128/jvi.74.15.7146-7150.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. King C. A., Marshall J. S., Alshurafa H., Anderson R. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol. 2000 Aug;74(15):7146–7150. doi: 10.1128/jvi.74.15.7146-7150.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Kontny U., Kurane I., Ennis F. A. Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol. 1988 Nov;62(11):3928–3933. doi: 10.1128/jvi.62.11.3928-3933.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Koraka P., Suharti C., Setiati T. E., Mairuhu A. T., Van Gorp E., Hack C. E., Juffrie M., Sutaryo J., Van Der Meer G. M., Groen J. Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J Clin Microbiol. 2001 Dec;39(12):4332–4338. doi: 10.1128/JCM.39.12.4332-4338.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Koraka Penelopie, Murgue Bernadette, Deparis Xavier, Setiati Tatty E., Suharti Catarina, van Gorp Eric C. M., Hack C. E., Osterhaus Albert D. M. E., Groen Jan. Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity. J Med Virol. 2003 May;70(1):91–98. doi: 10.1002/jmv.10358. [DOI] [PubMed] [Google Scholar]
  66. Kuno G., Gubler D. J., Santiago de Weil N. S. Antigen capture ELISA for the identification of dengue viruses. J Virol Methods. 1985 Oct;12(1-2):93–103. doi: 10.1016/0166-0934(85)90011-4. [DOI] [PubMed] [Google Scholar]
  67. Kurane I., Brinton M. A., Samson A. L., Ennis F. A. Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J Virol. 1991 Apr;65(4):1823–1828. doi: 10.1128/jvi.65.4.1823-1828.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Kurane I., Ennis F. A. Induction of interferon alpha from human lymphocytes by autologous, dengue virus-infected monocytes. J Exp Med. 1987 Oct 1;166(4):999–1010. doi: 10.1084/jem.166.4.999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Kurane I., Innis B. L., Hoke C. H., Jr, Eckels K. H., Meager A., Janus J., Ennis F. A. T cell activation in vivo by dengue virus infection. J Clin Lab Immunol. 1995;46(1):35–40. [PubMed] [Google Scholar]
  70. Kurane I., Innis B. L., Nimmannitya S., Nisalak A., Meager A., Ennis F. A. High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg. 1993 Feb;48(2):222–229. doi: 10.4269/ajtmh.1993.48.222. [DOI] [PubMed] [Google Scholar]
  71. Kurane I., Innis B. L., Nimmannitya S., Nisalak A., Meager A., Janus J., Ennis F. A. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest. 1991 Nov;88(5):1473–1480. doi: 10.1172/JCI115457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Kurane I., Innis B. L., Nimmannitya S., Nisalak A., Rothman A. L., Livingston P. G., Janus J., Ennis F. A. Human immune responses to dengue viruses. Southeast Asian J Trop Med Public Health. 1990 Dec;21(4):658–662. [PubMed] [Google Scholar]
  73. Kurane I., Innis B. L., Nisalak A., Hoke C., Nimmannitya S., Meager A., Ennis F. A. Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest. 1989 Feb;83(2):506–513. doi: 10.1172/JCI113911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Kurane I., Meager A., Ennis F. A. Induction of interferon alpha and gamma from human lymphocytes by dengue virus-infected cells. J Gen Virol. 1986 Aug;67(Pt 8):1653–1661. doi: 10.1099/0022-1317-67-8-1653. [DOI] [PubMed] [Google Scholar]
  75. La Russa V. F., Innis B. L. Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clin Haematol. 1995 Mar;8(1):249–270. doi: 10.1016/s0950-3536(05)80240-9. [DOI] [PubMed] [Google Scholar]
  76. Lee H. L., Khadri M. S., Chiang Y. F. Preliminary field evaluation of the combined adulticidal, larvicidal, and wall residual activity of ULV-applied bifenthrin against mosquitoes. J Vector Ecol. 1997 Dec;22(2):146–149. [PubMed] [Google Scholar]
  77. Libraty D. H., Pichyangkul S., Ajariyakhajorn C., Endy T. P., Ennis F. A. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol. 2001 Apr;75(8):3501–3508. doi: 10.1128/JVI.75.8.3501-3508.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Libraty Daniel H., Young Paul R., Pickering Darren, Endy Timothy P., Kalayanarooj Siripen, Green Sharone, Vaughn David W., Nisalak Ananda, Ennis Francis A., Rothman Alan L. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis. 2002 Sep 16;186(8):1165–1168. doi: 10.1086/343813. [DOI] [PubMed] [Google Scholar]
  79. Libraty Daniel H., Young Paul R., Pickering Darren, Endy Timothy P., Kalayanarooj Siripen, Green Sharone, Vaughn David W., Nisalak Ananda, Ennis Francis A., Rothman Alan L. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis. 2002 Sep 16;186(8):1165–1168. doi: 10.1086/343813. [DOI] [PubMed] [Google Scholar]
  80. Lin C. F., Lei H. Y., Liu C. C., Liu H. S., Yeh T. M., Wang S. T., Yang T. I., Sheu F. C., Kuo C. F., Lin Y. S. Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol. 2001 Feb;63(2):143–149. [PubMed] [Google Scholar]
  81. Lin Chiou-Feng, Lei Huan-Yao, Shiau Ai-Li, Liu Hsiao-Sheng, Yeh Trai-Ming, Chen Shun-Hua, Liu Ching-Chuan, Chiu Shu-Chen, Lin Yee-Shin. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J Immunol. 2002 Jul 15;169(2):657–664. doi: 10.4049/jimmunol.169.2.657. [DOI] [PubMed] [Google Scholar]
  82. Littaua R., Kurane I., Ennis F. A. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol. 1990 Apr 15;144(8):3183–3186. [PubMed] [Google Scholar]
  83. Liu Ching-Chuan, Huang Kao-Jean, Lin Yee-Shin, Yeh Trai-Ming, Liu Hsiao-Sheng, Lei Huan-Yao. Transient CD4/CD8 ratio inversion and aberrant immune activation during dengue virus infection. J Med Virol. 2002 Oct;68(2):241–252. doi: 10.1002/jmv.10198. [DOI] [PubMed] [Google Scholar]
  84. Loke H., Bethell D. B., Phuong C. X., Dung M., Schneider J., White N. J., Day N. P., Farrar J., Hill A. V. Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis. 2001 Nov 13;184(11):1369–1373. doi: 10.1086/324320. [DOI] [PubMed] [Google Scholar]
  85. Loke Hsin, Bethell Delia, Phuong Cao Xuan Thanh, Day Nick, White Nicholas, Farrar Jeremy, Hill Adrian. Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg. 2002 Jul;67(1):102–106. doi: 10.4269/ajtmh.2002.67.102. [DOI] [PubMed] [Google Scholar]
  86. Lum L. C., Lam S. K., Choy Y. S., George R., Harun F. Dengue encephalitis: a true entity? Am J Trop Med Hyg. 1996 Mar;54(3):256–259. doi: 10.4269/ajtmh.1996.54.256. [DOI] [PubMed] [Google Scholar]
  87. Martínez E., Guzmán M. G., Valdés M., Soler M., Kourí G. Fiebre del dengue y dengue hemorrágico en infantes con infección primaria. Rev Cubana Med Trop. 1993;45(2):97–101. [PubMed] [Google Scholar]
  88. Mathew A., Kurane I., Green S., Vaughn D. W., Kalayanarooj S., Suntayakorn S., Ennis F. A., Rothman A. L. Impaired T cell proliferation in acute dengue infection. J Immunol. 1999 May 1;162(9):5609–5615. [PubMed] [Google Scholar]
  89. Mathew A., Kurane I., Rothman A. L., Zeng L. L., Brinton M. A., Ennis F. A. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest. 1996 Oct 1;98(7):1684–1691. doi: 10.1172/JCI118964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Mentor N. A., Kurane I. Dengue virus infection of human T lymphocytes. Acta Virol. 1997 Jun;41(3):175–176. [PubMed] [Google Scholar]
  91. Messer William B., Gubler Duane J., Harris Eva, Sivananthan Kamalanayani, de Silva Aravinda M. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis. 2003 Jul;9(7):800–809. doi: 10.3201/eid0907.030038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Messer William B., Vitarana U. Tissa, Sivananthan Kamalanayani, Elvtigala Jayanthi, Preethimala L. D., Ramesh R., Withana Nalini, Gubler Duane J., De Silva Aravinda M. Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever. Am J Trop Med Hyg. 2002 Jun;66(6):765–773. doi: 10.4269/ajtmh.2002.66.765. [DOI] [PubMed] [Google Scholar]
  93. Mohan B., Patwari A. K., Anand V. K. Hepatic dysfunction in childhood dengue infection. J Trop Pediatr. 2000 Feb;46(1):40–43. doi: 10.1093/tropej/46.1.40. [DOI] [PubMed] [Google Scholar]
  94. Munasinghe D. R., Amarasekera P. J., Fernando C. F. An epidemic of dengue-like fever in Ceylon (chikungunya--a clinical and haematological study. Ceylon Med J. 1966 Dec;11(4):129–142. [PubMed] [Google Scholar]
  95. Mustafa A. S., Elbishbishi E. A., Agarwal R., Chaturvedi U. C. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol. 2001 Apr;30(3):229–233. doi: 10.1111/j.1574-695X.2001.tb01575.x. [DOI] [PubMed] [Google Scholar]
  96. Méndez Angela, González Gerardo. Dengue hemorrágico en niños: diez años de experiencia clínica. Biomedica. 2003 Jun;23(2):180–193. [PubMed] [Google Scholar]
  97. Míguez-Burbano M. J., Jaramillo C. A., Palmer C. J., Shor-Posner G., Velásquez L. S., Lai H., Baum M. K. Total immunoglobulin E levels and dengue infection on San Andrés Island, Colombia. Clin Diagn Lab Immunol. 1999 Jul;6(4):624–626. doi: 10.1128/cdli.6.4.624-626.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Narayanan Manjith, Aravind M. A., Thilothammal N., Prema R., Sargunam C. S. Rex, Ramamurty Nalini. Dengue fever epidemic in Chennai--a study of clinical profile and outcome. Indian Pediatr. 2002 Nov;39(11):1027–1033. [PubMed] [Google Scholar]
  99. Nawa M., Ichikawa Y., Inouye S. Serotyping of dengue viruses by an enzyme-linked immunosorbent assay. Jpn J Med Sci Biol. 1985 Oct-Dec;38(5-6):217–221. doi: 10.7883/yoken1952.38.217. [DOI] [PubMed] [Google Scholar]
  100. Nguyen T. L., Nguyen T. H., Tieu N. T. The impact of dengue haemorrhagic fever on liver function. Res Virol. 1997 Jul-Aug;148(4):273–277. doi: 10.1016/s0923-2516(97)88364-1. [DOI] [PubMed] [Google Scholar]
  101. Nisalak Ananda, Endy Timothy P., Nimmannitya Suchitra, Kalayanarooj Siripen, Thisayakorn Usa, Scott Robert M., Burke Donald S., Hoke Charles H., Innis Bruce L., Vaughn David W. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg. 2003 Feb;68(2):191–202. [PubMed] [Google Scholar]
  102. Pancharoen C., Mekmullica J., Thisyakorn U. Primary dengue infection: what are the clinical distinctions from secondary infection? Southeast Asian J Trop Med Public Health. 2001 Sep;32(3):476–480. [PubMed] [Google Scholar]
  103. Pancharoen Chitsanu, Rungsarannont Atchara, Thisyakorn Usa. Hepatic dysfunction in dengue patients with various severity. J Med Assoc Thai. 2002 Jun;85 (Suppl 1):S298–S301. [PubMed] [Google Scholar]
  104. Perich M. J., Davila G., Turner A., Garcia A., Nelson M. Behavior of resting Aedes aegypti (Culicidae: Diptera) and its relation to ultra-low volume adulticide efficacy in Panama City, Panama. J Med Entomol. 2000 Jul;37(4):541–546. doi: 10.1603/0022-2585-37.4.541. [DOI] [PubMed] [Google Scholar]
  105. Pinheiro F. P., Corber S. J. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Stat Q. 1997;50(3-4):161–169. [PubMed] [Google Scholar]
  106. Platt K. B., Linthicum K. J., Myint K. S., Innis B. L., Lerdthusnee K., Vaughn D. W. Impact of dengue virus infection on feeding behavior of Aedes aegypti. Am J Trop Med Hyg. 1997 Aug;57(2):119–125. doi: 10.4269/ajtmh.1997.57.119. [DOI] [PubMed] [Google Scholar]
  107. Qiu F. X., Gubler D. J., Liu J. C., Chen Q. Q. Dengue in China: a clinical review. Bull World Health Organ. 1993;71(3-4):349–359. [PMC free article] [PubMed] [Google Scholar]
  108. Rabablert J., Dharakul T., Yoksan S., Bhamarapravati N. Dengue virus specific T cell responses to live attenuated monovalent dengue-2 and tetravalent dengue vaccines. Asian Pac J Allergy Immunol. 2000 Dec;18(4):227–235. [PubMed] [Google Scholar]
  109. Raghupathy R., Chaturvedi U. C., Al-Sayer H., Elbishbishi E. A., Agarwal R., Nagar R., Kapoor S., Misra A., Mathur A., Nusrat H. Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol. 1998 Nov;56(3):280–285. doi: 10.1002/(sici)1096-9071(199811)56:3<280::aid-jmv18>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  110. Raviprakash K., Marques E., Ewing D., Lu Y., Phillips I., Porter K. R., Kochel T. J., August T. J., Hayes C. G., Murphy G. S. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF. Virology. 2001 Nov 10;290(1):74–82. doi: 10.1006/viro.2001.1136. [DOI] [PubMed] [Google Scholar]
  111. Richards A. L., Bagus R., Baso S. M., Follows G. A., Tan R., Graham R. R., Sandjaja B., Corwin A. L., Punjabi N. The first reported outbreak of dengue hemorrhagic fever in Irian Jaya, Indonesia. Am J Trop Med Hyg. 1997 Jul;57(1):49–55. doi: 10.4269/ajtmh.1997.57.49. [DOI] [PubMed] [Google Scholar]
  112. Rico-Hesse Rebeca. Microevolution and virulence of dengue viruses. Adv Virus Res. 2003;59:315–341. doi: 10.1016/s0065-3527(03)59009-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Rosen L. Sexual transmission of dengue viruses by Aedes albopictus. Am J Trop Med Hyg. 1987 Sep;37(2):398–402. [PubMed] [Google Scholar]
  114. Rothman A. L., Kanesa-thasan N., West K., Janus J., Saluzzo J. F., Ennis F. A. Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine. Vaccine. 2001 Sep 14;19(32):4694–4699. doi: 10.1016/s0264-410x(01)00236-5. [DOI] [PubMed] [Google Scholar]
  115. Sabchareon Arunee, Lang Jean, Chanthavanich Pornthep, Yoksan Sutee, Forrat Rémi, Attanath Phanorsi, Sirivichayakul Chukiate, Pengsaa Krisana, Pojjaroen-Anant Chanathep, Chokejindachai Watcharee. Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses. Am J Trop Med Hyg. 2002 Mar;66(3):264–272. doi: 10.4269/ajtmh.2002.66.264. [DOI] [PubMed] [Google Scholar]
  116. Sarasombath S., Suvatte V., Homchampa P. Kinetics of lymphocyte subpopulations in dengue hemorrhagic fever/dengue shock syndrome. Southeast Asian J Trop Med Public Health. 1988 Dec;19(4):649–656. [PubMed] [Google Scholar]
  117. Sierra Beatríz, García Gissel, Pérez Ana B., Morier Luis, Rodríguez Rayner, Alvarez Mayling, Guzmán María G. Long-term memory cellular immune response to dengue virus after a natural primary infection. Int J Infect Dis. 2002 Jun;6(2):125–128. doi: 10.1016/s1201-9712(02)90073-1. [DOI] [PubMed] [Google Scholar]
  118. Simmons M., Murphy G. S., Kochel T., Raviprakash K., Hayes C. G. Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine. Am J Trop Med Hyg. 2001 Nov;65(5):420–426. doi: 10.4269/ajtmh.2001.65.420. [DOI] [PubMed] [Google Scholar]
  119. Soni A., Chugh K., Sachdev A., Gupta D. Management of dengue fever in ICU. Indian J Pediatr. 2001 Nov;68(11):1051–1055. doi: 10.1007/BF02722356. [DOI] [PubMed] [Google Scholar]
  120. Srivastava V. K., Suri S., Bhasin A., Srivastava L., Bharadwaj M. An epidemic of dengue haemorrhagic fever and dengue shock syndrome in Delhi: a clinical study. Ann Trop Paediatr. 1990;10(4):329–334. doi: 10.1080/02724936.1990.11747453. [DOI] [PubMed] [Google Scholar]
  121. Stephens H. A. F., Klaythong R., Sirikong M., Vaughn D. W., Green S., Kalayanarooj S., Endy T. P., Libraty D. H., Nisalak A., Innis B. L. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens. 2002 Oct;60(4):309–318. doi: 10.1034/j.1399-0039.2002.600405.x. [DOI] [PubMed] [Google Scholar]
  122. Sukri Nono C., Laras Kanti, Wandra Toni, Didi Sukman, Larasati Ria P., Rachdyatmaka Josef R., Osok Stevie, Tjia Petrus, Saragih John M., Hartati Sri. Transmission of epidemic dengue hemorrhagic fever in easternmost Indonesia. Am J Trop Med Hyg. 2003 May;68(5):529–535. doi: 10.4269/ajtmh.2003.68.529. [DOI] [PubMed] [Google Scholar]
  123. Tadano M., Okuno Y., Fukunaga T., Fukai K. Retrospective serological studies on dengue epidemics in Osaka and Okinawa. Biken J. 1983 Dec;26(4):165–167. [PubMed] [Google Scholar]
  124. Thavara U., Tawatsin A., Chansang C., Kong-ngamsuk W., Paosriwong S., Boon-Long J., Rongsriyam Y., Komalamisra N. Larval occurrence, oviposition behavior and biting activity of potential mosquito vectors of dengue on Samui Island, Thailand. J Vector Ecol. 2001 Dec;26(2):172–180. [PubMed] [Google Scholar]
  125. Thein S., Aaskov J., Myint T. T., Shwe T. N., Saw T. T., Zaw A. Changes in levels of anti-dengue virus IgG subclasses in patients with disease of varying severity. J Med Virol. 1993 Jun;40(2):102–106. doi: 10.1002/jmv.1890400205. [DOI] [PubMed] [Google Scholar]
  126. Thisyakorn U., Nimmannitya S. Nutritional status of children with dengue hemorrhagic fever. Clin Infect Dis. 1993 Feb;16(2):295–297. doi: 10.1093/clind/16.2.295. [DOI] [PubMed] [Google Scholar]
  127. Thu H. M., Aye K. M., Thein S. The effect of temperature and humidity on dengue virus propagation in Aedes aegypti mosquitos. Southeast Asian J Trop Med Public Health. 1998 Jun;29(2):280–284. [PubMed] [Google Scholar]
  128. Tripathi B. K., Gupta B., Sinha R. S., Prasad S., Sharma D. K. Experience in adult population in dengue outbreak in Delhi. J Assoc Physicians India. 1998 Mar;46(3):273–276. [PubMed] [Google Scholar]
  129. Van Benthem B. H. B., Khantikul N., Panart K., Kessels P. J., Somboon P., Oskam L. Knowledge and use of prevention measures related to dengue in northern Thailand. Trop Med Int Health. 2002 Nov;7(11):993–1000. doi: 10.1046/j.1365-3156.2002.00950.x. [DOI] [PubMed] [Google Scholar]
  130. Vezzani Darío, Schweigmann Nicolás. Suitability of containers from different sources as breeding sites of Aedes aegypti (L.) in a cemetery of Buenos Aires City, Argentina. Mem Inst Oswaldo Cruz. 2002 Oct 15;97(6):789–792. doi: 10.1590/s0074-02762002000600006. [DOI] [PubMed] [Google Scholar]
  131. Vitarana T., de Silva H., Withana N., Gunasekera C. Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. Ceylon Med J. 1991 Jun;36(2):63–65. [PubMed] [Google Scholar]
  132. Wali J. P., Biswas A., Chandra S., Malhotra A., Aggarwal P., Handa R., Wig N., Bahl V. K. Cardiac involvement in Dengue Haemorrhagic Fever. Int J Cardiol. 1998 Mar 13;64(1):31–36. doi: 10.1016/s0167-5273(98)00008-4. [DOI] [PubMed] [Google Scholar]
  133. Wali J. P., Biswas A., Handa R., Aggarwal P., Wig N., Dwivedi S. N. Dengue haemorrhagic fever in adults: a prospective study of 110 cases. Trop Doct. 1999 Jan;29(1):27–30. doi: 10.1177/004947559902900110. [DOI] [PubMed] [Google Scholar]
  134. Wang S., He R., Patarapotikul J., Innis B. L., Anderson R. Antibody-enhanced binding of dengue-2 virus to human platelets. Virology. 1995 Oct 20;213(1):254–257. doi: 10.1006/viro.1995.1567. [DOI] [PubMed] [Google Scholar]
  135. Watts D. M., Burke D. S., Harrison B. A., Whitmire R. E., Nisalak A. Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am J Trop Med Hyg. 1987 Jan;36(1):143–152. doi: 10.4269/ajtmh.1987.36.143. [DOI] [PubMed] [Google Scholar]
  136. Yang K. D., Yeh W. T., Yang M. Y., Chen R. F., Shaio M. F. Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production. J Med Virol. 2001 Feb;63(2):150–157. [PubMed] [Google Scholar]
  137. Young P. R., Hilditch P. A., Bletchly C., Halloran W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol. 2000 Mar;38(3):1053–1057. doi: 10.1128/jcm.38.3.1053-1057.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. van Gorp Eric C. M., Suharti Catharina, Mairuhu Albert T. A., Dolmans Wil M. V., van Der Ven Johanna, Demacker Pierre N. M., van Der Meer Jos W. M. Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. Clin Infect Dis. 2002 Mar 21;34(8):1150–1153. doi: 10.1086/339539. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES